Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Actinium Pharmaceuticals
Actinium Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Alabama at Birmingham